Estrogen-like activity and prevention effect of bone loss in calcium deficient ovariectomized rats by the extract of Pleurotus eryngii

Phytotherapy Research

Volumn 20, Issue 8, 2006, Pages 659-664

  Shimizu, Kuniyoshi ^a   Yamanaka, Maiko ^a   Gyokusen, Mayumi ^a   Kaneko, Shuhei ^b   Tsutsui, Mototake ^c   Sato, Junichi ^c   Sato, Ikuo ^c   Sato, Masao ^a   Kondo, Ryuichiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Forestry and Forest Products Research Institute   (Japan)

^c CHISSO CORPORATION   (Japan)

Author keywords

Bone protection; Estrogenic activity; Mushroom; Osteoporosis; Pleurotaceae; Pleurotus eryngii

Indexed keywords

FULVESTRANT; PLANT EXTRACT; PLEUROTUS ERYNGII EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; BONE DENSITY; CALCIUM DEFICIENCY; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG ACTIVITY; ESTROGEN DEFICIENCY; FEMALE; HUMAN; HUMAN CELL; MUSHROOM; NONHUMAN; OSTEOLYSIS; PLEUROTUS; PLEUROTUS ERYNGII; RAT; UTERUS WEIGHT;

ANIMALS; BONE DENSITY; BONE RESORPTION; CALCIUM; CELL LINE, TUMOR; CELL PROLIFERATION; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; OSTEOPOROSIS; OVARIECTOMY; PLANT EXTRACTS; PLEUROTUS; RATS; RATS, SPRAGUE-DAWLEY;

BASIDIOMYCOTA; PLEUROTUS ERYNGII;

EID: 33747227454     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.1927     Document Type: Article

References (25)

1. Bok JW, Lermer L, Chilton J, Klingeman HG, Towers GH. 1999. Antitumor sterols from the mycelia of Cordyceps sinensis. Phytochemistry 51: 891-898.
2. Brzozowski AM, Pike AC, Dauter Z et al. 1997. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389: 753-758.
3. Cassidy A. 1999. Potential tissue selectivity of dietary phytoestrogens and estrogens. Curr Opin Lipidol 10: 47-52.
4. Chan RY, Chen WF, Dong A, Guo D, Wong MS. 2002. Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng. J Clin Endocrinol Metab 87: 3691-3695.
5. Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PW, Anderson JJ. 1993. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 329:1141-1146.
6. Frost HM, Jee WS. 1992. On the rat model of human osteopenias and osteoporoses. Bone Miner 8: 227-236.
7. Gehm BD, McAndrews JM, Chien PY, Jameson JL. 1997. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 94: 14138-14143.
8. Genant HK, Baylink DJ, Gallagher JC. 1989. Estrogens in the prevention of osteoporosis in postmenopausal women. Am J Obstet Gynecol 161: 1842-1846.
9. Kalu DN. 1991. The ovariectomized rat model of postmenopausal bone loss. Bone Miner 15: 175-191.
10. Kim HJ, Bae YC, Park RW et al. 2002. Bone-protecting effect of safflower seeds in ovariectomized rats. Calcif Tissue Int 71: 88-94.
11. Kolta S, De Vernejoul MC, Meneton P, Fechtenbaum J, Roux C. 2003. Bone mineral measurements in mice: comparison of two devices. J Clin Densitom 6: 251-258.
12. Kumar V, Green S, Stack G, Berry M, Jin JR, Chambon P. 1987. Functional domains of the human estrogen receptor. Cell 51: 941-951.
13. Leclercq G, Heuson JC. 1979. Physiological and pharmacological effects of estrogens in breast cancer. Biochim Biophys Acta 560: 427-455.
14. Milligan SR, Kalita JC, Heyerick A, Rong H, De Cooman L, De Keukeleire D. 1999. Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. J Clin Endocrinol Metab 84: 2249-2252.
15. Murkies AL, Wilcox G, Davis SR. 1998. Clinical review 92: Phytoestrogens. J Clin Endocrinol Metab 83: 297-303.
16. Paech K, Webb P, Kuiper GG et al. 1997. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 277: 1508-1510.
17. Persson I, Weiderpass E, Bergkvist L, Bergström R, Schairer C. 1999. Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement. Cancer Causes Control 10: 253-260.
18. Simkin-Silverman LR, Wing RR. 2000. Weight gain during menopause: is it inevitable or can it be prevented? Postgrad Med J 108: 47-50.
19. Somjen D, Amir-Zaltsman Y, Gayer B et al. 2002. 6-Carboxymethyl genistein: a novel selective oestrogen receptor modulator (SERM) with unique, differential effects on the vasculature, bone and uterus. J Endocrinol 173: 415-427.
20. Sudhir K, Komesaroff PA. 1999. Clinical review 110: Cardiovascular actions of estrogens in men. J Clin Endocrinol Metab 84: 3411-3415.
21. Tchernof A, Poehlman ET, Despres JP. 2000. Body fat distribution, the menopause transition, and hormone replacement therapy. Diabetes Metab 26: 12-20.
22. Tham DM, Gardner CD, Haskell WL. 1998. Clinical review 97: Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 83: 2223-2235.
23. Wu J, Wang X, Chiba H et al. 2004. Combined intervention of soy isoflavone and moderate exercise prevents body fat elevation and bone loss in ovariectomized mice. Metabolism 53: 942-948.
24. Yaoita Y, Yoshihara Y, Kakuda R, Machida K, Kikuchi M. 2002. New sterols from two edible mushrooms, Pleurotus eryngii and Panellus serotinus. Chem Pharm Bull 50: 551-553.
25. Zava DT, Duwe G. 1997. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 27: 31-40.